RETT Syndrome With Proven MECP2 Mutation
Rare Disease·MeSH: Rett Syndrome
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| nti164 | Innovation Pharmaceuticals Inc. (IPIX) |
Frequently asked questions
How many drugs are in development for RETT Syndrome With Proven MECP2 Mutation?
BioSniper tracks 1 drug in development for RETT Syndrome With Proven MECP2 Mutation across 1 company.
How many clinical trials target RETT Syndrome With Proven MECP2 Mutation?
There are 1 clinical trial targeting RETT Syndrome With Proven MECP2 Mutation tracked by BioSniper.
Deep-dive into RETT Syndrome With Proven MECP2 Mutation
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis